Rare Absence of CD79alpha in B-ALLs is not Associated with Altered Prognosis

نویسندگان
Shastri, Malvika ID 1
kotru, Mrinalini ID 2
Gupta, Richa ID 3
Garg, Neha ID 4

1 Junior Resident,Department of Pathology, UCMS and GTBH

2 Professor, Department of Pathology, UCMS and GTBH

3 Professor, Department of Pathology, UCMS and GTBH

4 senior Resident, Department of Pathology, UCMS and GTBH

doi
10.58209/ijbc.14.1.29
چکیده

Background: The diagnosis of B-cell acute lymphoblastic leukemia (B-ALL) on the basis of the World Health Organization (WHO) recommendations in 2016 requires the expression of CD19 with CD79a (CD79a), cCD22 and CD10. CD79a is an integral B cell antigen expressed at all stages. Its absence in B-ALL has only been rarely ...

کلیدواژه‌ها
B-cell acute lymphoblastic leukemia, CD79a expression, Flow cytometry, Immunophenotyping, Prognosis